Myriad Genetics to Acquire Rules-Based Medicine for $80M

The acquisition is expected to help build Myriad's companion diagnostics franchise.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories